Pegzerepoetin alfa
Term · Oncology and biomedicine · MLC-T-ONC-015934
A pegylated form of recombinant human erythropoietin, a glycosylated protein naturally produced in the kidney that stimulates erythrocyte production in the bone marrow. Pegzerepoetin alfa may reverse anemias induced by cancer therapy.
| Identifier | MLC-T-ONC-015934 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | methoxy polyethylene glycol-epoetin beta; continuous erythropoietin receptor activator |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015934",
"term": "Pegzerepoetin alfa",
"field": "Oncology and biomedicine",
"definition": "A pegylated form of recombinant human erythropoietin, a glycosylated protein naturally produced in the kidney that stimulates erythrocyte production in the bone marrow. Pegzerepoetin alfa may reverse anemias induced by cancer therapy.",
"synonyms": [
"methoxy polyethylene glycol-epoetin beta",
"continuous erythropoietin receptor activator"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/pegzerepoetin-alfa/"
}
Record 12,875 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.